Harrow (HROW) Capital Leases (2014 - 2022)
Harrow (HROW) posted quarterly Capital Leases of $7000.0 for Q1 2022, down 56.25% year-over-year from $16000.0 in Q1 2021, and down 30.0% quarter-over-quarter from $10000.0 in Q4 2021.
Harrow (HROW) Capital Leases (2014 - 2022) Analysis & Trends
Harrow's Capital Leases history runs 9 years deep, the most recent figure standing at $7000.0 for Q1 2022.
- In Q1 2022, Capital Leases fell 56.25% year-over-year to $7000.0; the TTM figure through Mar 2022 stood at $7000.0 (down 56.25% YoY), while the FY2021 annual figure was $10000.0, down 41.18% from the prior year.
- Capital Leases for Q1 2022 stood at $7000.0, down from $10000.0 in the prior quarter.
- The five-year high for Capital Leases was $546000.0 in Q1 2018, with the low at $7000.0 in Q1 2022.
- The 5-year median for Capital Leases is $22000.0 (2020), against an average of $77800.0.
- The sharpest annual moves came in 2019 and 2020: Capital Leases plunged 94.14% in 2019, then decreased 24.14% in 2020.
- Harrow's Capital Leases stood at $363000.0 in 2018, then plunged by 92.84% to $26000.0 in 2019, then tumbled by 34.62% to $17000.0 in 2020, then sank by 41.18% to $10000.0 in 2021, then fell by 30.0% to $7000.0 in 2022.
- Business Quant data shows HROW's Capital Leases at $7000.0 in Q1 2022, $10000.0 in Q4 2021, and $12000.0 in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Harrow | 1.58 Bn | 1.49 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 14,000.00 |
| Mar 31, 2021 | 16,000.00 |
| Dec 31, 2020 | 17,000.00 |
| Sep 30, 2020 | 20,000.00 |
| Jun 30, 2020 | 22,000.00 |
| Mar 31, 2020 | 24,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Sep 30, 2019 | 29,000.00 |
| Jun 30, 2019 | 29,000.00 |
| Mar 31, 2019 | 32,000.00 |
| Jun 30, 2018 | 363,000.00 |
| Mar 31, 2018 | 546,000.00 |
| Dec 31, 2017 | 720,000.00 |
| Sep 30, 2017 | 883,000.00 |
| Jun 30, 2017 | 1.04 Mn |
| Mar 31, 2017 | 1.18 Mn |
| Dec 31, 2016 | 1.32 Mn |